Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 30.49-6.23-32.1036.7145.25

What is the latest Core EBITDA Growth ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Growth ratio of DIVIS LABORATORIES is 30.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202530.49
Mar2024-6.23
Mar2023-32.10
Mar202236.71
Mar202145.25

How is Core EBITDA Growth of DIVIS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 30.49
Positive
Mar2024 -6.23
Negative
Mar2023 -32.1
Negative
Mar2022 36.71
-18.87
Mar2021 45.25 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹162,864.3 Cr -7.1% -11.5% 32.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,478.0 Cr -6.5% -4.7% -5.1% Stock Analytics
CIPLA ₹120,121.0 Cr -4.3% -0.1% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,327.0 Cr -5.8% 6.1% 13.3% Stock Analytics
MANKIND PHARMA ₹105,380.0 Cr -0.6% 5.1% 31.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,907.8 Cr -5.8% -6.8% -11% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

-7.1%

-11.5%

32.7%

SENSEX

-1.2%

-3.5%

-0.5%


You may also like the below Video Courses